» Articles » PMID: 39514465

Elevated Plasma Progranulin Levels in the Acute Phase Are Correlated with Recovery of Left Ventricular Function in the Chronic Phase in Patients with Acute Myocardial Infarction

Overview
Journal PLoS One
Date 2024 Nov 8
PMID 39514465
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Progranulin is a secreted glycoprotein that regulates inflammation and wound healing. However, plasma progranulin levels in the acute phase and their clinical significance in patients with acute myocardial infarction (AMI) remain to be elucidated.

Objective: We aimed to investigate the relationship between the increase in plasma progranulin levels in the acute phase and the recovery of left ventricular function in the chronic phase in AMI patients.

Method And Result: Eighteen AMI patients were followed up for 6 months. Blood samples were collected from the antecubital vein on day 0 (on admission) and day 7 in the acute phase. The control group consisted of patients without significant coronary artery stenosis, as assessed by cardiac catheterization (n = 16). Plasma progranulin levels were measured by enzyme-linked immunosorbent assay. Echocardiography was performed in the acute (within 7 days) and chronic (6 months) phases of AMI to evaluate left ventricular ejection fraction using the modified Simpson's method. Plasma progranulin levels in the AMI group on day 0 (69.5 ± 24.6 ng/mL) were similar to those in the control group (84.2 ± 47.1 ng/mL). There was a significant increase in progranulin levels in the AMI group on day 7 (104.2 ± 52.0 ng/mL) compared with day 0. The increase in plasma progranulin levels in the acute phase was positively correlated with the increase in left ventricular ejection fraction between the acute and chronic phases. Among various factors, only plasma progranulin levels were favorably correlated with left ventricular functional recovery in the chronic phase.

Conclusion: The increase in plasma progranulin levels in the acute phase may serve as a predictive biomarker and a contributer for the recovery of left ventricular function in the chronic phase in patients with AMI.

References
1.
Kessenbrock K, Frohlich L, Sixt M, Lammermann T, Pfister H, Bateman A . Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J Clin Invest. 2008; 118(7):2438-47. PMC: 2430496. DOI: 10.1172/JCI34694. View

2.
Hosokawa M, Kondo H, Serrano G, Beach T, Robinson A, Mann D . Accumulation of multiple neurodegenerative disease-related proteins in familial frontotemporal lobar degeneration associated with granulin mutation. Sci Rep. 2017; 7(1):1513. PMC: 5431430. DOI: 10.1038/s41598-017-01587-6. View

3.
Chareonthaitawee P, Christian T, Hirose K, Gibbons R, Rumberger J . Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction. J Am Coll Cardiol. 1995; 25(3):567-73. DOI: 10.1016/0735-1097(94)00431-O. View

4.
Sasaki T, Shimazawa M, Kanamori H, Yamada Y, Nishinaka A, Kuse Y . Effects of progranulin on the pathological conditions in experimental myocardial infarction model. Sci Rep. 2020; 10(1):11842. PMC: 7367277. DOI: 10.1038/s41598-020-68804-7. View

5.
Minatoguchi S, Takemura G, Chen X, Wang N, Uno Y, Koda M . Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation. 2004; 109(21):2572-80. DOI: 10.1161/01.CIR.0000129770.93985.3E. View